Low Level laser Therapy (LLLT) Cold Laser - THOR Laser

Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

What is Cold Laser Therapy?

Cold Laser Therapy is a colloquial term for photobiomodulation or Low Level Laser Therapy (LLLT).

It is a light therapy using lasers or LEDs to improve tissue repair, reduce pain and inflammation wherever the beam is applied. Usually applied by a doctor, therapist or technician, treatments take about 10 minutes and should be applied two or more times a week.

Cold Laser has been used for many years on sports injuries, arthritic joints, neuropathic pain syndromes, back and neck pain. Over 300 randomised clinical trials have been published on Cold Laser, half of which are on pain.

THOR customers include British and US military, Premier Division soccer teams, Olympic teams, Formula 1, rugby and cricket team therapists as well as specialist pain clinics in the UK and USA.

In the last 10 years sixteen systematic reviews have found in favour of LLLT / Photobiomodulation Therapy

  • 2018 - National Institute Of Health And Care Excellence (NICE) guidance for the UK NHS recommends laser therapy for oral mucositis. Click here
  • 2017 - UK NIHR funded RCT on the Clinical and Cost Effectiveness of Low Level Laser in the Management of Oral Mucositis in Head and Neck Cancer Irradiation, 10 NHS hospitals, 380 patients in progress. Click here
  • 2017 - Low Level Laser improves survival of head and neck cancer patients. Click here
  • 2017 - American College of Physicians Guidelines include a "strong recommendation" for Low-Level Laser Therapy as a non-invasive Treatments for Acute, Subacute & Chronic Low Back Pain. Click here
  • 2016 - BMJ LLLT for chronic non-specific low back pain: a systematic review and meta-analysis of randomised controlled trials found "moderate quality of evidence" and "clinically important benefits" in the short term. Click here
  • 2014 - 30% reduction of the costs of hospitalisation in PBM Oral Mucositis patients. Click here
  • 2014 - MASCC guideline revisions recommend oncologists to use of LLLT/PBM to reduce the incidence and severity of Oral Mucositis. Click Here.
  • 2013 - Journal Applied Oral Science.  TMJ Systematic review  "it seems clear that the use of laser brings benefits when properly applied and administered". Click Here.
  • 2012 - Multinational Association for Supportive Cancer Care (MASSC) systematic review recommends LLLT/PBM for oral mucositis. Click here
  • 2011 - European Society for Medical Oncology (ESMO) systematic review suggest LLLT/PBM for reducing duration and severity of oral mucositis. Click here
  • 2011 - British Medical Journal (BMJ) Clinical Guidelines "Likely to be beneficial for short-term pain relief & improvement of function". Click here
  • 2010 - The International Association for the Study of Pain (Global Task Force on musculoskeletal pain) recommend laser for myofascial pain syndrome. Click here
  • 2010 - British Journal of Sports Medicine, systematic review of surgical and conservative interventions for frozen shoulder found "strong evidence" for LLLT/PBM. Click here 
  • 2010 - American Physical Therapy Association guidelines recommend LLLT/PBM for Achilles tendonitis. Click here
  • 2009 - The Lancet "LLLT/PBM reduces pain immediately after treatment in acute neck pain and for up to 22 weeks in patients with chronic neck pain". Click here
  • 2008 - World Health Organisation (Bone and Joint Task Force) recommended LLLT/PBM for neck pain. Click Here

THOR Cold Laser Newsletter (See previous edition)

Please add me to the monthly THOR training, research and conference Newsletter.

See more video interviews


Product information and purchase enquiry

Sorry for the long form.

We are a global company and our computer needs to know who to direct your enquiry to.

* Mandatory field - this automatically directs your enquiry to the correct department



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Regulatory approvals include FDA, European CE mark, TGA Australia, Health Canada